{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:41:42Z","timestamp":1789040502888,"version":"build-2803163510"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Survival rates are usually used to evaluate the effect of cancer treatment and prevention. This study aims to analyze the 5-year relative survival of non-Hodgkin lymphoma (NHL) in United States using population-based cancer registry data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A period analysis was used to evaluate the improvement in long-term prognosis of patients with NHL from 2004 to 2018, and a generalized linear model was developed to predict the 5-year relative survival rates of patients during 2019\u20132023 based on data from the SEER database stratified by age, sex, race and subtype.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In this study, relative survival improved for all NHL, although the extent of improvement varied by sex, age group and lymphoma subtype. Survival improvement was also noted for NHL subtypes, although the extent varied, with marginal-zone lymphoma having the highest 5-year relative survival rate (92.5%) followed by follicular lymphoma (91.6%) and chronic lymphocytic leukemia\/small lymphocytic lymphoma (87.3%). Across all subtypes, survival rates were slightly higher in females than in males. Survival rates are lower in the elderly than in the young. Furthermore, the study demonstrated that black patients had lower NHL survival rates than white patients. Survival rates for NHL were higher in rural areas than in urban areas. Patients with extra-nodal NHL had a higher survival rate than patients with nodal NHL.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Overall, patient survival rates for NHL gradually improved during 2004\u20132018. The trend continues with a survival rate of 75.2% for the period 2019\u20132023. Analysis by NHL subtype and subgroups indicating that etiology and risk factors may differ by subtype. Identification of population-specific prevention strategies and treatments for each subtype can be aided by understanding these variations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.942122","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T06:31:50Z","timestamp":1664260310000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Analysis and prediction of relative survival trends in patients with non-Hodgkin lymphoma in the United States using a model-based period analysis method"],"prefix":"10.3389","volume":"12","author":[{"given":"Shuping","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aozi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3204","article-title":"Non-Hodgkin lymphoma","volume":"362","author":"Bowzyk Al-Naeeb","year":"2018","journal-title":"BMJ"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B3","author":"Surveillance","year":"2018"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23344","article-title":"Non-Hodgkin lymphoma and obesity: A pooled analysis from the InterLymph Consortium","volume":"122","author":"Willett","year":"2008","journal-title":"Int J Cancer."},{"key":"B5","volume-title":"SEER Cancer Statistics Review, 1975-2015","author":"Noone","year":"2018"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8644","article-title":"Cancer treatment disparities in HIV-infected individuals in the United States","volume":"32","author":"Suneja","year":"2014","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00277-004-0939-7","article-title":"Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology","volume":"84","author":"M\u00fcller","year":"2005","journal-title":"Ann Hematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.734616","article-title":"Survival of patients with non-Hodgkin lymphoma in Germany in the early 21st century","volume":"54","author":"Pulte","year":"2013","journal-title":"Leukemia Lymphoma"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/824691","article-title":"Socioeconomic impacts on survival differ by race\/ethnicity among adolescents and young adults with non-hodgkin's lymphoma","volume":"2010","author":"Kent","year":"2010","journal-title":"J Cancer Epidemiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40779-021-00338-z","article-title":"Data mining in clinical big data: the frequently used databases, steps, and methodological models","volume":"8","author":"Wu","year":"2021","journal-title":"Military Med Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/jebm.12373","article-title":"Brief introduction of medical database and data mining technology in big data era","volume":"13","author":"Yang","year":"2020","journal-title":"J Evidence-Based Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/jco.1988.6.12.1838","article-title":"The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma","volume":"6","author":"Vose","year":"1988","journal-title":"J Clin Oncol"},{"key":"B13","unstructured":"Center for disease control and prevention. life tables"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3414\/ME0563","article-title":"periodR - an R package to calculate long-term cancer survival estimates using period analysis","volume":"48","author":"Holleczek","year":"2009","journal-title":"Methods Inf Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4065\/80.8.1087","article-title":"Non-Hodgkin lymphoma: diagnosis and treatment","volume":"80","author":"Ansell","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015106","article-title":"Long-term time trends in incidence, survival and mortality of lymphomas by subtype among adults in Manitoba, Canada: A population-based study using cancer registry data","volume":"7","author":"Ye","year":"2017","journal-title":"BMJ Open"},{"key":"B17","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.131375","article-title":"Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus","volume":"57","author":"Whiteman","year":"2008","journal-title":"Gut"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0693","article-title":"Cigarette smoking and risk of non-Hodgkin lymphoma: A pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph)","volume":"14","author":"Morton","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-009-0111-4","article-title":"Alcohol consumption and non-Hodgkin lymphoma survival","volume":"4","author":"Han","year":"2010","journal-title":"J Cancer Surviv."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0273","article-title":"Contributions of HIV to Non-Hodgkin Lymphoma Mortality Trends in the United States","volume":"25","author":"Howlader","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3571-7","article-title":"Stage I non-Hodgkin lymphoma: No plateau in disease-specific survival","volume":"98","author":"Chihara","year":"2019","journal-title":"Ann Hematol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2010.515979","article-title":"Hodgkin's lymphoma therapy: Past, present, and future","volume":"11","author":"Rathore","year":"2010","journal-title":"Expert Opin Pharmacother."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.1398","article-title":"Follicular lymphoma, survival, and rituximab: Is it time to declare victory","volume":"26","author":"Horning","year":"2008","journal-title":"J Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.1003","article-title":"Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma","volume":"24","author":"Habermann","year":"2006","journal-title":"J Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.10.861","article-title":"Chemotherapeutic Options in Chronic Lymphocytic Leukemia: A Meta-analysis of the Randomized Trials","volume":"91","year":"1999","journal-title":"JNCI: J Natl Cancer Institute"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.59.060906.220345","article-title":"A decade of rituximab: Improving survival outcomes in non-Hodgkin's lymphoma","volume":"59","author":"Molina","year":"2008","journal-title":"Annu Rev Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1517\/14656560902895715","article-title":"Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma","volume":"10","author":"Prichard","year":"2009","journal-title":"Expert Opin Pharmacother."},{"key":"B29","first-page":"60","article-title":"Age-Adjusted Incidence Rates and Time Trends of Non-Hodgkin Lymphoma by Subtype, 2000-2015","volume-title":"Capstone Experience","author":"Le","year":"2019"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/medsci9010005","article-title":"Epidemiology of Non-Hodgkin's Lymphoma","volume":"9","author":"Thandra","year":"2021","journal-title":"Med Sci (Basel)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/jncimonographs\/lgu012","article-title":"Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: The InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Wang","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-07-295683","article-title":"Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia","volume":"117","author":"Shanafelt","year":"2011","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.6674","article-title":"Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma","volume":"28","author":"Drake","year":"2010","journal-title":"J Clin Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.8820","article-title":"Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study","volume":"27","author":"Engert","year":"2009","journal-title":"J Clin Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12837","article-title":"Age disparities in survival from lymphoma and myeloma: a comparison between US and England","volume":"165","author":"Pulte","year":"2014","journal-title":"Br J Haematol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.23","article-title":"Diagnosing cancer earlier: reviewing the evidence for improving cancer survival","author":"Hiom","year":"2015","journal-title":"Br J Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmi008","article-title":"Sex hormones and the immune response in humans","volume":"11","author":"Bouman","year":"2005","journal-title":"Hum Reprod Update"},{"key":"B38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canep.2014.12.001","article-title":"Racial differences in three major NHL subtypes: Descriptive epidemiology","volume":"39","author":"Li","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"B39","first-page":"5","article-title":"Lower 24-Month Relative Survival among Black Patients with Non- Hodgkin's Lymphoma: An Analysis of the SEER Data 1997-2015","volume":"2","author":"Nieto","year":"2021","journal-title":"J Clin Haematol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92846-A","article-title":"Race or class versus race and class: mortality differentials in the united states","volume":"336","author":"Navarro","year":"1990","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1089\/jayao.2014.0037","article-title":"Survival Differences by Race\/Ethnicity and Neighborhood Socioeconomic Status in Adolescents and Young Adults Diagnosed with Non-Hodgkin Lymphoma","volume":"4","author":"Chao","year":"2015","journal-title":"J Adolesc Young Adult Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds023","article-title":"Changes in survival by ethnicity of patients with cancer between 1992-1996 and 2002-2006: is the discrepancy decreasing","volume":"23","author":"Pulte","year":"2012","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34163","article-title":"Global patterns of non-Hodgkin lymphoma in 2020","volume":"151","author":"Mafra","year":"2022","journal-title":"Int J Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0386","article-title":"Survival disparities by insurance type for patients aged 15-64 years with non-Hodgkin lymphoma","volume":"20","author":"Pulte","year":"2015","journal-title":"oncologist"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23914","article-title":"Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma","volume":"113","author":"Wang","year":"2008","journal-title":"Cancer"},{"key":"B46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","article-title":"Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"B47","first-page":"39","article-title":"Primary CNS lymphoma in immunocompetent: a review of literature and our experience from Kashmir","volume":"21","author":"Makhdoomi","year":"2011","journal-title":"Turkish Neurosurg"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1037_19","article-title":"Non-Hodgkin's lymphoma: A review","volume":"9","author":"Singh","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"B49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5045\/kjh.2012.47.2.92","article-title":"Epidemiologic overview of malignant lymphoma","volume":"47","author":"Huh","year":"2012","journal-title":"Korean J Hematol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000248014.78020.7a","article-title":"Primary small intestinal malignant tumors: survival analysis of 48 postoperative patients","volume":"42","author":"Cao","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-321","article-title":"Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)","volume":"11","author":"Kim","year":"2011","journal-title":"BMC Cancer"},{"key":"B52","article-title":"Extranodal non-Hodgkin's lymphomas\u2013a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomas","volume":"9","author":"Lal","year":"","journal-title":"Asian Pacific J Cancer Prev"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609067590","article-title":"Primary extranodal non-Hodgkin's lymphoma in adults: clinicopathological and survival characteristics","volume":"21","author":"Economopoulos","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1179\/102453308X316149","article-title":"Extranodal lymphoma: A comparative study","volume":"13","author":"AlShemmari","year":"2008","journal-title":"Hematology"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.942122\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T06:31:58Z","timestamp":1664260318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.942122\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":54,"alternative-id":["10.3389\/fonc.2022.942122"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.942122","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"article-number":"942122"}}